$291.54+5.51 (+1.93%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$291.540.00 (0.00%)
After hours: Nov 16, 2026, 4:21 PM ET
Tenet Healthcare (THC) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~225.0%/yr (FY21→FY25), net margin 11.1%, and free cash flow (~$2.5B) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($B)▲3.1%
21.3
FY21→FY25CAGR +225.0%/yr
Net income ($B)▼41.8%
2.4
FY21→FY25CAGR +12.5%/yr
Free cash flow ($B)▲126.7%
2.5
FY21→FY25CAGR +29.1%/yr
Diluted EPS▼52.6%
15.49
buyback-liftedCAGR +16.5%/yr
What the receipts whisper · what a headline number hides
Share count
−16.3%
108.6mn → 90.8mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$1.0B
steady at 4.7% of revenue (+8.5% YoY).
Returns vs FCF
90%
$2.3B returned vs $2.5B of FCF in FY25. Buybacks + dividends covered by cash flow.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)
11¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 3911.0% → 59.2%. Net margin 11.1% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 22,154.0 | 21,310.0 | 20,675.0 | 20,564.0 | 19,368.0 | 191.0 | ▲3.1% | +225.0% |
Cost of revenue | 8,800.0 | 8,705.0 | 8,801.0 | 9,146.0 | 8,844.0 | −7,279.0 | ▼1.1% | −0.5% (22→25) |
Gross profit | 13,354.0 | 12,605.0 | 11,874.0 | 11,418.0 | 10,524.0 | 7,470.0 | ▲6.2% | +14.0% |
Selling, general & admin | 8,613.0 | 8,303.0 | 8,139.0 | 8,105.0 | 7,271.0 | 4,206.0 | ▲2.0% | +18.5% |
Total operating expenses | 7,954.0 | 9,097.0 | 5,918.0 | 8,908.0 | 8,191.0 | 4,817.0 | ▲53.7% | +17.2% |
Operating incomefeeds ROC rank | 5,400.0 | 3,508.0 | 5,956.0 | 2,510.0 | 2,333.0 | 2,653.0 | ▼41.1% | +7.2% |
Other income, net | −668.0 | −708.0 | −708.0 | −893.0 | −988.0 | −765.0 | — | — |
Pretax income | 4,732.0 | 2,800.0 | 5,248.0 | 1,617.0 | 1,345.0 | 1,888.0 | ▼46.6% | +10.4% |
Income tax | 918.0 | 433.0 | 1,184.0 | 306.0 | 344.0 | 411.0 | ▼63.4% | +1.3% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 3,814.0 | 2,367.0 | 4,064.0 | 1,311.0 | 1,001.0 | 1,476.0 | ▼41.8% | +12.5% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 34.48 | 15.49 | 32.70 | 5.71 | 3.79 | 8.42 | ▼52.6% | +16.5% |
Diluted shares (mn) | 80.60 | 90.83 | 97.88 | 104.80 | 110.52 | 108.57 | ▼7.2% | −4.4% |
| Margins | ||||||||
Gross margin41st pct in Healthcare | 60.3% | 59.2% | 57.4% | 55.5% | 54.3% | 3911.0% | ▲1.7pp | −3851.8pp |
Operating margin | 24.4% | 16.5% | 28.8% | 12.2% | 12.0% | 1389.0% | ▼12.3pp | −1372.5pp |
Net margin81st pct in Healthcare | 17.2% | 11.1% | 19.7% | 6.4% | 5.2% | 772.8% | ▼8.5pp | −761.7pp |
† TTM = trailing four quarters through 2026-09-30.
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-17 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Tenet Healthcare's revenue last fiscal year?
Tenet Healthcare reported revenue of $21.3B in fiscal 2025, up 3.1% from fiscal 2024.
What was Tenet Healthcare's net income?
Tenet Healthcare reported net income of $2.4B in fiscal 2025, a net margin of 11.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

